Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.53
-0.16 (-2.81%)
At close: Mar 5, 2026, 4:00 PM EST
5.55
+0.02 (0.36%)
After-hours: Mar 5, 2026, 7:55 PM EST
Compass Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
35
Market Cap
983.58M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortrea Holdings | 2.72B |
| Xeris Biopharma Holdings | 291.85M |
| Valneva SE | 211.09M |
| Maravai LifeSciences Holdings | 185.74M |
| UroGen Pharma | 109.79M |
| Inhibrx Biosciences | 1.40M |
CMPX News
- 20 hours ago - Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 - Seeking Alpha
- 7 weeks ago - Compass Therapeutics, Inc. (CMPX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Compass Therapeutics Provides Corporate Update - GlobeNewsWire
- 2 months ago - Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Compass Therapeutics Announces Key Leadership Appointments - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 3 months ago - Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha